Literature DB >> 7847430

Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia.

M T Draelos1, A M Jacobson, K Weinger, B Widom, C M Ryan, D M Finkelstein, D C Simonson.   

Abstract

BACKGROUND: To determine the impact of glycemic control, gender, and other relevant parameters on cognitive function during exposure to different blood glucose levels in patients with insulin-dependent diabetes mellitus (IDDM), we examined neuropsychologic function during experimentally induced periods of hyperglycemia and hypoglycemia.
METHODS: We studied 20 men and 22 women, aged 18 to 44 years, with IDDM duration of 3 to 14 years and HbA1 values ranging from 5.8% to 18.0% (nondiabetic range 5.4% to 7.4%). We used a controlled experimental setting involving tests of sensory perceptual processing, simple motor abilities, attention, learning and memory, language, and spatial and constructional abilities at plasma glucose levels of 2.2, 5.6, 8.9, 14.4, and 21.1 mmol/L. Patients were blind to the glucose level. Tests used at each glucose level included reaction time (simple and choice), digit vigilance, trail making part B, word recall, digit sequence learning, and verbal fluency.
RESULTS: All aspects of neuropsychologic function were diminished at 2.2 mmol/L when compared with basal levels of performance at 8.9 mmol/L, whereas no alterations were observed at 14.4 or 21.1 mmol/L. Tests involving associative learning, attention, and mental flexibility were the most affected during hypoglycemia. Glycemic control was not correlated with neuropsychologic function at any glucose level. Women demonstrated less of an impairment in neuropsychologic function than men at 2.2 mmol/L.
CONCLUSIONS: Cognitive function in IDDM patients was generally well-preserved even at substantially elevated blood glucose levels. Deficits in all relevant areas of cognitive function occurred during hypoglycemia (2.2 mmol/L), irrespective of prior glycemic control, and women with IDDM were less cognitively impaired than men with IDDM during hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847430     DOI: 10.1016/S0002-9343(99)80397-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  25 in total

Review 1.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Authors:  Malin Nilsson; Nicole Jensen; Michael Gejl; Marianne L Bergmann; Heidi Storgaard; Mette Zander; Kamilla Miskowiak; Jørgen Rungby
Journal:  Diabetologia       Date:  2019-07-31       Impact factor: 10.122

3.  Intrahippocampal administration of amyloid-β(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism.

Authors:  Jiah Pearson-Leary; Ewan C McNay
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 4.  Effects of Intermittent Fasting, Caloric Restriction, and Ramadan Intermittent Fasting on Cognitive Performance at Rest and During Exercise in Adults.

Authors:  Anissa Cherif; Bart Roelands; Romain Meeusen; Karim Chamari
Journal:  Sports Med       Date:  2016-01       Impact factor: 11.136

5.  Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study.

Authors:  John E J Gallacher; Janet Pickering; Peter C Elwood; Anthony J Bayer; John W Yarnell; Yoav Ben-Shlomo
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes.

Authors:  R E Warren; N N Zammitt; I J Deary; B M Frier
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

7.  Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist.

Authors:  Meena Garg; Manikkavasagar Thamotharan; Gerald Pan; Paul W N Lee; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

8.  Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study.

Authors:  S Knight; E Northam; S Donath; A Gardner; N Harkin; C Taplin; P Joy; F J Cameron; G R Ambler
Journal:  Diabetologia       Date:  2008-11-06       Impact factor: 10.122

9.  Peroxisome proliferator-activated receptor-gamma agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring.

Authors:  Shilpa Oak; Cang Tran; Maria-Olivia Castillo; Shanthie Thamotharan; Manikkavasagar Thamotharan; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

10.  Effects of acute insulin-induced hypoglycaemia on psychomotor function: people with type 1 diabetes are less affected than non-diabetic adults.

Authors:  J Geddes; I J Deary; B M Frier
Journal:  Diabetologia       Date:  2008-08-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.